29,30 Despite these benefits, the trials assessing the efficacy of LOLA suffer from several biases related to inadequate blinding, incomplete data, selective reporting, and pharmaceutical funding
They directly reduce neuroinflammation in the brain and systemic inflammation in the blood vessels
In addition, they are S-100 and dopa positive and do not show Schwann cell morphology, nor do they react with antibodies to myelin basic protein
Losing weight depends on person to person
For now, the gap between natural supplements and prescription medications remains enormous
Also, GLP-1s have not been shown to be used long-term